Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shunda Du

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
World Journal of Surgical Oncology|October 1, 2024
Novel multifactor predictive model for postoperative survival in gallbladder cancer: a multi-center studyKaige Deng, Jiali Xing, Gang Xu, et al.
Nuclear Medicine Communications|June 8, 2013
A novel liver function evaluation system using radiopharmacokinetic modeling of technetium-99m-DTPA-galactosyl human serum albuminShunda Du, Yilei Mao, Junxiang Tong, et al.
BMC Cancer|January 20, 2026
Postoperative adjuvant TACE combined with lenvatinib and immune checkpoint inhibitors for hepatocellular carcinoma with high recurrence risks: a multicenter retrospective studyZiyue Huang, Taifeng Zhu, Xiaokun Chen, et al.
Journal of Translational Medicine|June 18, 2026
Multiomics prediction and immunogenic validation of personalized neoantigens in cholangiocarcinoma patientsBaoluhe Zhang, Bao Jin, Xueshuai Wan, et al.
Journal of Clinical Medicine|March 29, 2023
Safety and Perioperative Outcomes of Laparoscopic vs. Open Hepatectomy of Central-Located Liver Lesions: A Multicenter, Propensity Score-Matched, Retrospective Cohort StudyBao Jin, Muyi Yang, Yinhan Wang, et al.
Gut|August 13, 2025
Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trialXiang'an Wu, Dongmei Quan, Wei Li, et al.
Journal of Advanced Research|September 15, 2024
Developing Patient-Derived 3D-Bioprinting models of pancreatic cancerHang Sun, Yan Wang, Minghao Sun, et al.
Journal of Hepatocellular Carcinoma|October 27, 2025
Immunotherapy-Based Strategies versus Transcatheter Arterial Chemoembolization and the Impact of Treatment Duration in Hepatocellular Carcinoma with Microvascular Invasion: A Retrospective Multicenter Cohort StudyXiaokun Chen, Jiali Xing, Baoluhe Zhang, et al.
Heliyon|June 3, 2024
LINC02257 regulates colorectal cancer liver metastases through JNK pathwayXiangan Wu, Xiaokun Chen, Xiao Liu, et al.
Journal of Cancer|May 6, 2024
Neoadjuvant targeted immunotherapy followed by surgical resection versus upfront surgery for hepatocellular carcinoma with macrovascular invasion: A multicenter studyXiang'an Wu, Yuxin Wang, Sen Wang, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
World Journal of Surgical Oncology|October 1, 2024
Novel multifactor predictive model for postoperative survival in gallbladder cancer: a multi-center studyKaige Deng, Jiali Xing, Gang Xu, et al.
Nuclear Medicine Communications|June 8, 2013
A novel liver function evaluation system using radiopharmacokinetic modeling of technetium-99m-DTPA-galactosyl human serum albuminShunda Du, Yilei Mao, Junxiang Tong, et al.
BMC Cancer|January 20, 2026
Postoperative adjuvant TACE combined with lenvatinib and immune checkpoint inhibitors for hepatocellular carcinoma with high recurrence risks: a multicenter retrospective studyZiyue Huang, Taifeng Zhu, Xiaokun Chen, et al.
Journal of Translational Medicine|June 18, 2026
Multiomics prediction and immunogenic validation of personalized neoantigens in cholangiocarcinoma patientsBaoluhe Zhang, Bao Jin, Xueshuai Wan, et al.
Journal of Clinical Medicine|March 29, 2023
Safety and Perioperative Outcomes of Laparoscopic vs. Open Hepatectomy of Central-Located Liver Lesions: A Multicenter, Propensity Score-Matched, Retrospective Cohort StudyBao Jin, Muyi Yang, Yinhan Wang, et al.
Gut|August 13, 2025
Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trialXiang'an Wu, Dongmei Quan, Wei Li, et al.
Journal of Advanced Research|September 15, 2024
Developing Patient-Derived 3D-Bioprinting models of pancreatic cancerHang Sun, Yan Wang, Minghao Sun, et al.
Journal of Hepatocellular Carcinoma|October 27, 2025
Immunotherapy-Based Strategies versus Transcatheter Arterial Chemoembolization and the Impact of Treatment Duration in Hepatocellular Carcinoma with Microvascular Invasion: A Retrospective Multicenter Cohort StudyXiaokun Chen, Jiali Xing, Baoluhe Zhang, et al.
Heliyon|June 3, 2024
LINC02257 regulates colorectal cancer liver metastases through JNK pathwayXiangan Wu, Xiaokun Chen, Xiao Liu, et al.
Journal of Cancer|May 6, 2024
Neoadjuvant targeted immunotherapy followed by surgical resection versus upfront surgery for hepatocellular carcinoma with macrovascular invasion: A multicenter studyXiang'an Wu, Yuxin Wang, Sen Wang, et al.
Pageof 13